CD274 and chronic myelogenous leukemia, BCR-ABL1 positive: They showed that blocking the PD-1 signal using PD-1–deficient recipient mice or via the administration of the PD-L1 antibody restored CML-specific T-cell tolerance and prolonged survival of CML-BC mice.